Table 3.
Outlets in remote areas and non-remote areas with quality-assured artemisinin combination therapies in stock at endline in Ghana and Kenya, 2011–2012
| Country/Type of outlet | Remote areas | Non-remote areas | p value* | ||
|---|---|---|---|---|---|
| Percentage (95 % CI) | N | Percentage (95 % CI) | N | ||
| All QAACTs | |||||
| Ghana, total | 77.9 (67.0–85.9) | 149 | 83.8 (78.8–87.8) | 487 | 0.1634 |
| Public health facility | 96.2 (74.5–99.5) | 26 | 80.0 (63.6–90.1) | 55 | 0.0645 |
| Private not-for-profit health facilitya | 100.0 | 4 | 90.0 (57.5–98.4) | 10 | – |
| Private for-profit outlet | 68.0 (47.6–83.3) | 97 | 84.1 (78.5–88.5) | 422 | <0.0001 |
| Community health workera | 95.5 (80.0–99.1) | 22 | – | 0 | – |
| Kenya, total | 56.2 (43.4–68.2) | 392 | 70.8 (63.8–76.8) | 1223 | <0.0001 |
| Public health facility | 95.4 (82.2–98.9) | 51 | 96.4 (89.9–98.8) | 105 | 0.9999 |
| Private not-for-profit health facilitya | 100.0 | 15 | 98.6 (93.1–99.7) | 43 | 0.561 |
| Private for-profit outlet | 45.9 (30.0–62.6) | 325 | 65.5 (57.2–72.9) | 1075 | <0.0001 |
| Community health workera | 100.0 | 1 | – | 0 | – |
| QAACTs with AMFm Logo | |||||
| Ghana, total | 60.4 (37.7–79.3) | 149 | 81.5 (76.7–85.6) | 487 | <0.0001 |
| Public health facility | 84.6 (65.6–94.1) | 26 | 76.4 (59.4–87.7) | 55 | 0.3951 |
| Private not-for-profit health facilitya | 100.0 | 4 | 80.0 (49.4–94.2) | 10 | – |
| Private for-profit outlet | 66.0 (45.9–81.6) | 97 | 82.2 (76.9–86.5) | 422 | <0.0001 |
| Community health workera | 0.0 | 22 | 0 | – | |
| Kenya, total | 48.5 (36.2–61.0) | 392 | 64.0 (56.3–71.0) | 1223 | <0.0001 |
| Public health facility | 60.5 (44.6–74.4) | 51 | 68.9 (54.0–80.8) | 105 | 0.9913 |
| Private not-for-profit health facility | 73.3 (44.0–90.6) | 15 | 58.8 (37.0–77.6) | 43 | 0.3622 |
| Private for-profit outlet | 44.9 (29.2–61.8) | 325 | 63.5 (55.6–70.8) | 1075 | <0.0001 |
| Community health worker | 100.0 | 1 | – | 0 | – |
Percentages indicate the percentage of outlets in remote areas and non-remote areas that had quality-assured ACTs in stock at the time of the survey visit (n) among all outlets with any antimalarial in stock at the time of the survey visit (N), by type of outlet, according to country, 2011–2012. CI: Confidence interval; AMFm = Affordable Medicine Facility-malaria
* p value for Chi square testing for difference between remote and non-remote areas
aThese are presented in the table because they contribute to the country overall estimates; however, they are not discussed in the text because of the small sample